e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Cystic fibrosis: assessment and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm
H. X. Ong, C. Y. Loo, W. H. Lee, D. Traini, C. Whitchurch, P. Young (Southampton, United Kingdom; Sydney, Australia)
Source:
International Congress 2014 – Cystic fibrosis: assessment and treatment
Session:
Cystic fibrosis: assessment and treatment
Session type:
Oral Presentation
Number:
3443
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. X. Ong, C. Y. Loo, W. H. Lee, D. Traini, C. Whitchurch, P. Young (Southampton, United Kingdom; Sydney, Australia). LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm. Eur Respir J 2014; 44: Suppl. 58, 3443
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
Bronchiectasis: Bacteriological profile
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant
Staphylococcus
aureus
Isolates from Patients with Empyema Thoracis in Central Taiwan
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Targeting Antibiotics to Pseudomonas aeruginosa in Small airways (TAPAS) in patients with Cystic Fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Year: 2014
Bacterial Colonization of Airway Stents and The Effect of Colonization on Stent Course
Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches
Year: 2020
Imaging in Pleural Infections: The Radiation Adds Up
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
LATE-BREAKING ABSTRACT: Role of Interferon-á2b and Ribavirin in MERS-CoV Infection as Treatment and Prophylaxis
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Ventilator-Induced Lung Injury Increases Systemic Inflammation in Murine Pseudomonas Aeruginosa Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
Bronchial Lavage Exosome miRNA Correlates to Metabolic Disturbance in Patients with Pulmonary Acinetobacter Baumannii Infection
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Pulmonary actinomycosis: Successful treatment with oral antibiotics
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Microbiome in Cystic Fibrosis Exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept